Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC)

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Le QT, Petrik DW. (2005). Nonsurgical therapy for stages I and II non-small cell lung cancer. Hematol Oncol Clin North Am 19:237–61.
   PubMed Web of Science ®Google Scholar
• Shirvani SM, Jiang J, Chang JY, et al. (2012). Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 84:1060–70.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Bozzi E, Faviana P, et al. (2010). Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol 33:818–27.
   PubMed Web of Science ®Google Scholar
• Dupuy DE. (2009). Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology 251:617–18.
   PubMed Web of Science ®Google Scholar
• Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. (2010). Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21:S192–S203.
   PubMed Web of Science ®Google Scholar
• Sidoff L, Dupuy DE. (2016). Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia 33:25–33.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Zheng A, et al. (2014). Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 110:758–63.
   PubMed Web of Science ®Google Scholar
• Han X, Yang X, Ye X, et al. (2015). Computed tomography-guided percutaneous microwave ablation of patients 75 years of age and older with early-stage nonsmall cell lung cancer. Indian J Cancer 52(Suppl.2):e56–60.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6.
   PubMed Web of Science ®Google Scholar
• Folkman J, Watson K, Ingber D, Hanahan D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61.
   PubMed Web of Science ®Google Scholar
• Folkman J. (1997). Addressing tumor blood vessels. Nat Biotechnol 15:510.
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9–22.
   PubMed Web of Science ®Google Scholar
• Karayiannakis AJ, Syrigos KN, Zbar A, et al. (2002). Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery. Surgery 131:548–55.
   PubMed Web of Science ®Google Scholar
• Caine GJ, Stonelake PS, Lip GY, Blann AD. (2007). Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Cancer Lett 248:131–6.
   PubMed Web of Science ®Google Scholar
• Laack E, Kohler A, Kugler C, et al. (2002). Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol 13:1550–7.
   PubMed Web of Science ®Google Scholar
• Laack E, Scheffler A, Burkholder I, et al. (2005). Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Lung Cancer 50:51–8.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Stetler-Stevenson WG. (1999). Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43(Suppl):S42–S51.
   PubMed Web of Science ®Google Scholar
• Hrabec E, Strek M, Nowak D, Hrabec Z. (2001). Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med 95:1–4.
   PubMed Web of Science ®Google Scholar
• Ng CS, Wan S, Hui CW, et al. (2007). Video-assisted thoracic surgery lobectomy for lung cancer is associated with less immunochemokine disturbances than thoracotomy. Eur J Cardiothorac Surg 31:83–7.
   PubMed Web of Science ®Google Scholar
• Ng CS, Wan S, Wong RH, et al. (2012). Angiogenic response to major lung resection for non-small cell lung cancer with video-assisted thoracic surgical and open access. ScientificWorldJournal 2012:636754.
   PubMed Web of Science ®Google Scholar
• Tian W, Tong H, Sun Y, et al. (2014). [Changes in serum vascular endothelial growth factor and matrix metalloproteinase-9 after video-assisted thoracoscopic surgery and thoracotomic lobectomy in the treatment of patients with non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 17:24–9.
   PubMedGoogle Scholar
• Zhang LB, Wang B, Wang XY, Zhang L. (2015). Influence of video-assisted thoracoscopic lobectomy on immunological functions in non-small cell lung cancer patients. Med Oncol 32:201.
   PubMed Web of Science ®Google Scholar
• Huang G, Liu Q, Ye X, et al. (2014). Invasive pulmonary aspergillosis: a rare complication after microwave ablation. Int J Hyperthermia 30:412–17.
   PubMed Web of Science ®Google Scholar
• Ni Y, Bi J, Ye X, et al. (2016). Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: a pilot study. Medicine (Baltimore) 95:e3998.
   PubMed Web of Science ®Google Scholar
• Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3:861–5.
   PubMed Web of Science ®Google Scholar
• Erinjeri JP, Thomas CT, Samoilia A, et al. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. J Vasc Interv Radiol 2013;24:1105–12.
   PubMed Web of Science ®Google Scholar
• Wu F. Heat-based tumor ablation: role of the immune response. Adv Exp Med Biol 2016;880:131–53.
   PubMed Web of Science ®Google Scholar
• Han H, Silverman JF, Santucci TS, et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol 2001;8:72–9.
   PubMed Web of Science ®Google Scholar
• Liu Z, Dai H, Jia G, et al. (2015). Insufficient radiofrequency ablation promotes human hepatoma SMMC7721 cell proliferation by stimulating vascular endothelial growth factor overexpression. Oncol Lett 9:1893–6.
   PubMed Web of Science ®Google Scholar
• Xu M, Xie XH, Xie XY, et al. (2013). Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo. Acta Radiol 54:199–204.
   PubMed Web of Science ®Google Scholar
• Kong B, Michalski CW, Friess H, Kleeff J. (2010). Surgical procedure as an inducer of tumor angiogenesis. Exp Oncol 32:186–9.
   PubMedGoogle Scholar
• Nijkamp MW, van der Bilt JD, de Bruijn MT, et al. (2009). Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg 249:814–23.
   PubMed Web of Science ®Google Scholar
• Kumar G, Goldberg SN, Wang Y, et al. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. Eur Radiol 2016. [Epub ahead of print]. DOI:10.1007/s00330-016-4405-4
   Web of Science ®Google Scholar
• Jiang T, Zhang X, Ding J, et al. (2015). Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation. Int J Clin Exp Pathol 8:13945–56.
   PubMed Web of Science ®Google Scholar